Medtronic

NYSE: MDT · Real-Time Price · USD
82.97
0.56 (0.68%)
At close: May 30, 2025, 3:59 PM
83.15
0.21%
After-hours: May 30, 2025, 05:57 PM EDT

Medtronic Revenue Breakdown

Period Ending Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 24, 2020 Apr 26, 2019 Apr 27, 2018 Apr 28, 2017 Apr 29, 2016 Apr 24, 2015
Cardiac and Vascular Group Revenue 11.83B 11.57B 11.42B 10.47B 11.51B 11.35B 10.5B 10.2B 9.36B
Cardiac and Vascular Group Revenue Growth +2.23% +1.31% +9.12% -9.01% +1.33% +8.15% +2.96% +8.92% n/a
Diabetes Group Revenue 2.49B 2.26B 2.34B 2.37B 2.39B 2.14B 1.93B 1.86B 1.76B
Diabetes Group Revenue Growth +9.99% -3.25% -1.27% -0.96% +11.73% +11.05% +3.38% +5.79% n/a
Medical Surgical Revenue 8.42B 8.43B 9.14B n/a n/a n/a n/a n/a n/a
Medical Surgical Revenue Growth -0.19% -7.75% n/a n/a n/a n/a n/a n/a n/a
Neuroscience Group Revenue 9.41B 8.96B 8.78B n/a n/a n/a n/a n/a n/a
Neuroscience Group Revenue Growth +4.99% +1.99% n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020 Apr 26, 2019
Japan, Australia, New Zealand, Korea, Canada, And Western Europe Revenue 9.98B 9.41B 10.13B 9.81B 9.29B 9.63B
Japan, Australia, New Zealand, Korea, Canada, And Western Europe Revenue Growth +6.07% -7.09% +3.17% +5.69% -3.57% n/a
Middle East, Africa, Latin America, Eastern Europe, And Asia, Excluding Japan And Korea Revenue 5.82B 5.45B 5.43B 4.78B 4.71B 4.73B
Middle East, Africa, Latin America, Eastern Europe, And Asia, Excluding Japan And Korea Revenue Growth +6.92% +0.37% +13.59% +1.49% -0.53% n/a

Operating Expense Breakdown

Period Ending Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015
Selling, General, and Administrative Revenue 2.72B 2.76B 2.63B 2.73B 2.67B 2.69B 2.61B 2.62B 2.62B 2.62B 2.54B 2.52B 2.56B 2.62B 2.55B 2.59B 2.54B 2.6B 2.42B 2.36B 2.59B 2.62B 2.54B 2.62B 2.6B 2.6B 2.6B 2.55B 2.5B 2.44B 2.48B 2.48B 2.39B 2.42B 2.43B 2.36B 2.32B 2.34B 2.45B 2.4B 1.49B
Selling, General, and Administrative Revenue Growth -1.45% +4.99% -3.84% +2.17% -0.48% +2.79% -0.11% +0.04% -0.08% +3.07% +0.55% -1.41% -2.07% +2.67% -1.81% +2.25% -2.42% +7.57% +2.42% -8.77% -1.26% +3.03% -2.94% +0.92% -0.35% +0.31% +1.76% +2.12% +2.50% -1.89% +0.24% +3.81% -1.16% -0.49% +2.88% +1.86% -1.11% -4.33% +1.87% +61.67% n/a
Research and Development Revenue 675M 697M 676M 675M 695M 698M 668M 641M 688M 676M 692M 652M 668M 676M 750M 632M 601M 639M 621M 567M 573M 603M 587M 594M 561M 590M 585M 592M 558M 555M 548M 553M 530M 554M 556M 575M 546M 545M 558M 528M 373M
Research and Development Revenue Growth -3.16% +3.11% +0.15% -2.88% -0.43% +4.49% +4.21% -6.83% +1.78% -2.31% +6.13% -2.40% -1.18% -9.87% +18.67% +5.16% -5.95% +2.90% +9.52% -1.05% -4.98% +2.73% -1.18% +5.88% -4.92% +0.85% -1.18% +6.09% +0.54% +1.28% -0.90% +4.34% -4.33% -0.36% -3.30% +5.31% +0.18% -2.33% +5.68% +41.55% n/a